Literature DB >> 32430349

Postintravenous immunoglobulin stroke in a toddler with Down syndrome: a diagnostic challenge.

Teck-Hock Toh1,2,3, Everlyn Coxin Siew4,3, Chae-Hee Chieng4,3, Hussain Imam Mohd Ismail5.   

Abstract

Children with Down syndrome have a higher risk of stroke. Similarly, intravenous immunoglobulin (IV Ig) is also known to cause a stroke. We reported a 3-year-old boy with Down syndrome who presented with severe pneumonia and received IV Ig. He developed right hemiparesis 60 hours after the infusion. Blood investigations, echocardiography and carotid Doppler did not suggest vasculitis, thrombophilia or extracranial dissection. Brain computerised tomography (CT) showed acute left frontal and parietal infarcts. Initial magnetic resonance angiography (MRA) of cerebral vessels showed short segment attenuations of both proximal middle cerebral arteries and reduction in the calibre of bilateral supraclinoid internal carotid arteries. The boy was treated with enoxaparin and aspirin. He only had partial recovery of the hemiparesis on follow-up. A repeat MRA 13 months later showed parenchymal collateral vessels suggestive of moyamoya disease. We recommend imaging the cerebral vessels in children with a high risk of moyamoya before giving IV Ig. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  congenital disorders; immunological products and vaccines; moyamoya; stroke

Mesh:

Substances:

Year:  2020        PMID: 32430349      PMCID: PMC7239537          DOI: 10.1136/bcr-2019-233149

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  13 in total

1.  [A case of Down syndrome with moyamoya syndrome presenting extensive multiple cerebral infarction during measles infection].

Authors:  H Takasugi; T Maemoto; K Kitazawa; A Honda
Journal:  No To Hattatsu       Date:  2000-01

2.  Down syndrome and moyamoya: clinical presentation and surgical management.

Authors:  Alfred P See; Alexander E Ropper; Daniel L Underberg; Richard L Robertson; R Michael Scott; Edward R Smith
Journal:  J Neurosurg Pediatr       Date:  2015-04-03       Impact factor: 2.375

3.  Arterial thrombosis induced by IVIg and its treatment with tPA.

Authors:  Darin Okuda; Murray Flaster; James Frey; Kumaraswamy Sivakumar
Journal:  Neurology       Date:  2003-06-10       Impact factor: 9.910

4.  Asymptomatic moyamoya syndrome, atlantoaxial subluxation and basal ganglia calcification in a child with Down syndrome.

Authors:  Kyung Yeon Lee; Kun-Soo Lee; Young Cheol Weon
Journal:  Korean J Pediatr       Date:  2013-12-20

5.  Fatal thrombotic events during treatment of autoimmune thrombocytopenia with intravenous immunoglobulin in elderly patients.

Authors:  R K Woodruff; A P Grigg; F C Firkin; I L Smith
Journal:  Lancet       Date:  1986-07-26       Impact factor: 79.321

6.  High-dose intravenous immunoglobulin and serum viscosity: risk of precipitating thromboembolic events.

Authors:  M C Dalakas
Journal:  Neurology       Date:  1994-02       Impact factor: 9.910

7.  [Multiple arterial ischemic strokes in a child with moyamoya disease and Mycoplasma pneumoniae infection].

Authors:  F Greco; D Castellano Chiodo; A Sorge; S Perrini; G Sorge
Journal:  Minerva Pediatr       Date:  2006-02       Impact factor: 1.312

8.  Effect of high-dose intravenous immunoglobulin therapy on blood rheology.

Authors:  W H Reinhart; P E Berchtold
Journal:  Lancet       Date:  1992-03-14       Impact factor: 79.321

9.  The clinical features of 16 cases of stroke associated with administration of IVIg.

Authors:  James B Caress; Michael S Cartwright; Peter D Donofrio; James E Peacock
Journal:  Neurology       Date:  2003-06-10       Impact factor: 9.910

10.  Moyamoya and other causes of stroke in patients with Down syndrome.

Authors:  E Pearson; N J Lenn; W S Cail
Journal:  Pediatr Neurol       Date:  1985 May-Jun       Impact factor: 3.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.